{"disease":{"id":"intrahepatic-cholestasis","name":"intrahepatic cholestasis"},"drugs":{"marketed":[{"drug_id":"odevixibat","indication_name":"Pruritus in progressive familial intrahepatic cholestasis (PFIC)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Bylvay","generic_name":"ODEVIXIBAT","company_name":"Ipsen","drug_phase":"marketed","molecular_target":"Ileal sodium/bile acid cotransporter","drug_class":"Ileal Bile Acid Transporter Inhibitor [EPC]","quality_score":55,"revenue":null,"mechanism":"Bylvay works by blocking the ileal sodium/bile acid cotransporter, a protein that helps reabsorb bile acids in the intestines."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05687474","title":"Baby Detect : Genomic Newborn Screening","phase":"","overall_status":"COMPLETED","enrollment_count":6824,"lead_sponsor_name":"Centre Hospitalier Universitaire de Liege","has_results":false},{"nct_id":"NCT03930810","title":"NAtural Course and Prognosis of PFIC and Effect of Biliary Diversion","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":1500,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT04922580","title":"Predictors of Adverse Neonatal Outcomes in Intrahepatic Cholestasis of Pregnancy","phase":"","overall_status":"COMPLETED","enrollment_count":700,"lead_sponsor_name":"Daping Hospital and the Research Institute of Surgery of the Third Military Medical University","has_results":false},{"nct_id":"NCT06366659","title":"Unraveling the Pathogenesis of Pruritus in Intrahepatic Cholestasis of Pregnancy","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":600,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT03519399","title":"Bile Acid Effects in Fetal Arrhythmia Study","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT05637151","title":"Different Effects of Delayed Clamping on Neonatal Bilirubin Levels Between Pregnant Women With Intrahepatic Cholestasis of Pregnancy and Normal Pregnant Women","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Second Affiliated Hospital of Wenzhou Medical University","has_results":false},{"nct_id":"NCT06364969","title":"Investigation of the Pruritogens of Liver-related Diseases","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT05704517","title":"Progressive Familial Intrahepatic Cholestasis in Indian Children - Establishing an Indian PFIC Registry","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Institute of Liver and Biliary Sciences, India","has_results":false},{"nct_id":"NCT07497724","title":"Retrospective Observational Study of Odevixibat Outcomes in Patients With PFIC Versus an External Control Cohort (OvEC-PFIC)","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"Ipsen","has_results":false},{"nct_id":"NCT07191704","title":"A Study to Assess the Genetic Variations in Bile Flow Disorders: Linking Progressive Familial Intrahepatic Cholestasis (PFIC)-Related Genes to Symptoms in Adults With Recurrent Cholestasis in Spain","phase":"","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Ipsen","has_results":false},{"nct_id":"NCT06679972","title":"Impact of Intrahepatic Cholestasis of Pregnancy on Neonatal Respiratory Outcomes","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":120,"lead_sponsor_name":"Carol Davila University of Medicine and Pharmacy","has_results":false},{"nct_id":"NCT03659916","title":"Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":116,"lead_sponsor_name":"Albireo, an Ipsen Company","has_results":true},{"nct_id":"NCT05151913","title":"The Microbiome Composition in Women With Recurring Intrahepatic Cholestasis of Pregnancy (ICP)","phase":"","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"MetaboGen AB","has_results":false},{"nct_id":"NCT03834285","title":"Liver Disease in Pregnancy","phase":"","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"King's College Hospital NHS Trust","has_results":false},{"nct_id":"NCT03905330","title":"A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":93,"lead_sponsor_name":"Mirum Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT04185363","title":"An Extension Study of Maralixibat in Patients With Progressive Familial Intrahepatic Cholestasis (PFIC)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"Mirum Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT04890886","title":"Magnetic Resonance Imaging and Thermal Imaging of Adiposity in Neonates of Women With Metabolic Diseases","phase":"","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Guy's and St Thomas' NHS Foundation Trust","has_results":false},{"nct_id":"NCT07428226","title":"Serum Bile Acid Profiles in Patients With Intrahepatic Cholestasis of Pregnancy","phase":"","overall_status":"RECRUITING","enrollment_count":74,"lead_sponsor_name":"Jena University Hospital","has_results":false},{"nct_id":"NCT06193928","title":"Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)","phase":"","overall_status":"RECRUITING","enrollment_count":70,"lead_sponsor_name":"Mirum Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT07317193","title":"DEFINING THE GENETIC DRIVERS OF ADULT-ONSET CHOLESTATIC LIVER DISEASE","phase":"NA","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","has_results":false},{"nct_id":"NCT07293897","title":"A Database Study of Maralixibat (TAK-625) in Participants With Alagille Syndrome (ALGS) and Progressive Familial Intrahepatic Cholestasis (PFIC)","phase":"","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Takeda","has_results":false},{"nct_id":"NCT02057718","title":"Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 (Maralixibat) in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Mirum Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT07389031","title":"Maralixibat for Intrahepatic Cholestasis of Pregnancy","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":28,"lead_sponsor_name":"Imperial College London","has_results":false},{"nct_id":"NCT04729751","title":"A Study to Evaluate the Safety and Tolerability of Maralixibat in Infant Participants With Cholestatic Liver Diseases Including Progressive Familial Intrahepatic Cholestasis (PFIC) and Alagille Syndrome (ALGS).","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":27,"lead_sponsor_name":"Mirum Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT04071197","title":"Gastrostomy-Biliary Diversion: Innovative Management for Bile Canalicular Transport Disorders","phase":"NA","overall_status":"UNKNOWN","enrollment_count":20,"lead_sponsor_name":"National Liver Institute, Egypt","has_results":false},{"nct_id":"NCT07185919","title":"A Study of the Effectiveness, Safety and the Long-term Outcomes of Participants With Progressive Familial Intrahepatic Cholestasis (PFIC) Who Take Odevixibat (Bylvay) in South Korea","phase":"","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"Ipsen","has_results":false},{"nct_id":"NCT03082937","title":"An Open Label, Single-dose, Single Period ADME Study of A4250 in Healthy Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":6,"lead_sponsor_name":"Albireo","has_results":false},{"nct_id":"NCT05543187","title":"A Study of TAK-625 for the Treatment of Progressive Familial Intrahepatic Cholestasis (PFIC)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":5,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT04718961","title":"A Placebo-controlled Study of Volixibat in Subjects With Elevated Serum Bile Acids Associated With Intrahepatic Cholestasis of Pregnancy (OHANA)","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":4,"lead_sponsor_name":"Mirum Pharmaceuticals, Inc.","has_results":true},{"nct_id":"NCT03353454","title":"A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Mirum Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT04483531","title":"Odevixibat for the Treatment of Progressive Familial Intrahepatic Cholestasis","phase":"","overall_status":"APPROVED_FOR_MARKETING","enrollment_count":null,"lead_sponsor_name":"Albireo","has_results":false}],"total":31},"guidelines":[],"source":"Drug Landscape verified database"}